These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9552231

  • 1. How do I treat erythema nodosum, aphthous ulcerations, and pyoderma gangrenosum?
    Hanauer SB.
    Inflamm Bowel Dis; 1998 Feb; 4(1):70; discussion 73. PubMed ID: 9552231
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of extraintestinal manifestations of inflammatory bowel disease.
    Grand RJ.
    Inflamm Bowel Dis; 1998 Feb; 4(1):72; discussion 73. PubMed ID: 9552233
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of pyoderma gangrenosum, erythema nodosum, and aphthous ulcerations.
    Winter HS.
    Inflamm Bowel Dis; 1998 Feb; 4(1):71. PubMed ID: 9552232
    [No Abstract] [Full Text] [Related]

  • 5. [Extraintestinal complications of inflammatory bowel disease].
    Kinjo F, Iraha A, Chinen H, Ihama Y, Kishimoto K, Hokama A.
    Nihon Rinsho; 2012 Feb; 70 Suppl 1():261-5. PubMed ID: 23126101
    [No Abstract] [Full Text] [Related]

  • 6. [Cutaneous manifestations in inflammatory bowel disease].
    Chavez-Álvarez S, Gómez-Flores M, Ocampo-Candiani J.
    Gac Med Mex; 2016 Feb; 152(5):622-630. PubMed ID: 27792697
    [Abstract] [Full Text] [Related]

  • 7. Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease.
    Goldberg I, Finkel O, Gat A, Sprecher E, de Morentin HM.
    Isr Med Assoc J; 2014 Mar; 16(3):168-70. PubMed ID: 24761705
    [Abstract] [Full Text] [Related]

  • 8. Important cutaneous manifestations of inflammatory bowel disease.
    Trost LB, McDonnell JK.
    Postgrad Med J; 2005 Sep; 81(959):580-5. PubMed ID: 16143688
    [Abstract] [Full Text] [Related]

  • 9. [Ulcerative colitis concomitant with pyoderma gangrenosum and erythema nodosum--presentation of two cases].
    Wojas-Pelc A, Wielowieyska-Szybińska D, Setkowicz M, Szybiński P, Bogdaszewska-Czabanowska J.
    Przegl Lek; 2001 Sep; 58(10):945-9. PubMed ID: 11957826
    [Abstract] [Full Text] [Related]

  • 10. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M.
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Prinz Vavricka M, Navarini AA, French LE, Safroneeva E, Fournier N, Straumann A, Froehlich F, Fried M, Michetti P, Seibold F, Lakatos PL, Peyrin-Biroulet L, Schoepfer AM.
    Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
    [Abstract] [Full Text] [Related]

  • 13. [Skin manifestations of inflammatory diseases of the gastrointestinal tract].
    Piette F, Colombel JF, Delaporte E.
    Ann Dermatol Venereol; 1992 Aug; 119(4):297-306. PubMed ID: 1530244
    [No Abstract] [Full Text] [Related]

  • 14. Thalidomide and its dermatologic uses.
    Moraes M, Russo G.
    Am J Med Sci; 2001 May; 321(5):321-6. PubMed ID: 11370795
    [Abstract] [Full Text] [Related]

  • 15. Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease.
    Freeman HJ.
    Can J Gastroenterol; 2005 Oct; 19(10):603-6. PubMed ID: 16247522
    [Abstract] [Full Text] [Related]

  • 16. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
    Mebazaa A, Aounallah A, Naija N, Cheikh Rouhou R, Kallel L, El Euch D, Boubaker J, Mokni M, Filali A, Ben Osman A.
    Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
    [Abstract] [Full Text] [Related]

  • 17. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.
    Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, Aractingi S, Khosrotehrani K.
    Medicine (Baltimore); 2008 Sep; 87(5):281-293. PubMed ID: 18794711
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?
    Walker D, Orchard T.
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S200-1. PubMed ID: 18816647
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.